Does skeletal muscle insulin resistance impair postprandial glucose disposal and drive compensatory hyperinsulinemia and higher average glucose?

Skeletal muscle is the principal site of insulin-stimulated glucose uptake, clearing approximately 75% to 90% of circulating glucose after a meal. Consequently, disruptions in this pathway trigger a cascade of metabolic adaptations that fundamentally alter glucose and insulin dynamics.

Mechanisms of impaired disposal

• Under normal physiological conditions, postprandial insulin binds to its receptor, initiating a signaling cascade involving insulin receptor substrate-1 (IRS-1), phosphoinositide 3-kinase (PI3K), and Akt.
• This pathway regulates the key Rab-GAP protein TBC1D4, facilitating the translocation of glucose transporter 4 (GLUT4) vesicles from intracellular storage to the sarcolemma and T-tubules.
• In skeletal muscle insulin resistance, defects in proximal insulin signaling and cytoskeletal remodeling impair GLUT4 vesicle trafficking, substantially reducing glucose uptake and compromising postprandial glucose disposal.

Compensatory hyperinsulinemia and glycemia

• Reduced postprandial clearance leaves excess glucose in circulation, prompting pancreatic beta-cells to increase insulin secretion to maintain metabolic homeostasis.
• This feedback loop results in compensatory hyperinsulinemia, which temporarily compensates for muscle-level resistance to maintain near-normal glycemia.
• Over time, persistent defects in postprandial disposal—combined with progressive beta-cell dysfunction—limit the compensatory capacity, leading to prolonged postprandial hyperglycemia and driving up average daily blood glucose levels.

Bottom line

• Skeletal muscle insulin resistance directly impairs postprandial glucose disposal by disrupting the IRS-1/PI3K/Akt/GLUT4 translocation pathway, triggering compensatory hyperinsulinemia and eventually elevating average blood glucose as pancreatic compensation declines.